Researchers investigated the potential association between psoriasis and clinical markers of cognitive decline using data from the Rotterdam Study.

News

News
Wednesday, March 2, 2016
An oral Janus kinase inhibitor shows sustained efficacy over a 2 year period against chronic plaque psoriasis with 10 mg twice daily providing greater efficacy than 5 mg twice daily, according to a recent findings reported in an online paper in the Journal of the American Academy of Dermatology.
News
Wednesday, February 3, 2016
Apremilast improves clinical outcomes in patients with psoriatic arthritis and active psoriasis, according to results from the PALACE 3 randomized controlled trial.